Affordable Access

Publisher Website

A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.

Authors
Type
Published Article
Journal
New England Journal of Medicine
0028-4793
Publisher
New England Journal of Medicine
Publication Date
Volume
370
Issue
14
Pages
1316–1326
Identifiers
DOI: 10.1056/NEJMoa1310214
PMID: 24693891
Source
Medline

Abstract

In this study involving 123 women who could be evaluated, treatment with hyperimmune globulin did not significantly modify the course of primary CMV infection during pregnancy. (Funded by Agenzia Italiana del Farmaco; CHIP ClinicalTrials.gov number, NCT00881517; EudraCT no. 2008-006560-11.).

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F